Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Atara Biotherapeutics, Inc. (ATRA)

« Back to company index

ATRA Chatter Timeline

Stock Ticker for ATRA

Most Active Tweeters for ATRA

UserTweets
@WKRBNews 2
@Briefingcom 2
@fda_tracker 2
@ZolmaxNews 2
@dailypoliticaln 2

Recent Tweets for ATRA

tradingbotnyse @tradingbotnyse
Stocks with greater movement, last 15 minutes $ATRA +/- 1.35% Atara Biotherapeutics Inc. $PS +/- 0.57% Pluralsight… https://t.co/hmNySmJYTX
June 17th 2019, 2:06pm
DataTrials @DataTrials
$ATRA Phase 1|Phase 2 Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Di… https://t.co/GKHNSPa9b7
June 16th 2019, 11:06am
ChartMill @ChartMill
$ATRA has a bad technical rating, but it does show a decent setup pattern. https://t.co/XryaphCZFP https://t.co/n6ARegbZVQ
June 13th 2019, 6:06am
gulfgator33 @gulfgator33
$atra This stock has been great for me in the past, but right now it's been tough. trying to get a handle on it, bu… https://t.co/TdxrPElya3
June 12th 2019, 12:06pm
fda_tracker @fda_tracker
$ATRA Phase 2 trial w/est Jun completion date NCT01646645: https://t.co/YfJtMSp1iN Trial Tracker: https://t.co/aR7q5oJwjn
June 12th 2019, 9:06am
fda_tracker @fda_tracker
$ATRA Phase 2 trial w/est Jun completion date NCT02136797: https://t.co/e8jwenUcrw Trial Tracker: https://t.co/aR7q5oJwjn
June 11th 2019, 9:06am
WKRBNews @WKRBNews
Brokerages Expect Atara Biotherapeutics Inc $ATRA Will Post Earnings of -$1.45 Per Share https://t.co/yrLWil5cqJ #markets
June 8th 2019, 7:06pm
TickerReport @TickerReport
Citigroup Upgrades Atara Biotherapeutics $ATRA to Neutral https://t.co/n07F5rnw6a
June 7th 2019, 7:06am
dailypoliticaln @dailypoliticaln
Citigroup Upgrades Atara Biotherapeutics $ATRA to Neutral https://t.co/votZVI2lNB
June 7th 2019, 7:06am
WKRBNews @WKRBNews
Citigroup Upgrades Atara Biotherapeutics $ATRA to Neutral https://t.co/cWzyKktGOI #markets
June 7th 2019, 7:06am
bbnsnews @bbnsnews
Head-To-Head Survey: PDL BioPharma $PDLI vs. Atara Biotherapeutics $ATRA https://t.co/mH6phVabPC
June 7th 2019, 2:06am
ZolmaxNews @ZolmaxNews
Atara Biotherapeutics Inc $ATRA Expected to Post Earnings of -$1.45 Per Share https://t.co/uoS5zm4cat
June 6th 2019, 2:06pm
AmericanBanking @AmericanBanking
Recent Investment Analysts’ Ratings Updates for Atara Biotherapeutics $ATRA https://t.co/rKaqyCWf0A #stocks
June 6th 2019, 9:06am
mchilberg @mchilberg
Starting to pay attention to $ATRA as it approaches prior upper channel support #Genetherapy https://t.co/ycN3aiz1On
June 5th 2019, 1:06pm
Quantumup1 @Quantumup1
$ATRA FDA seems to like Atara's Tab-cel, trial size 'too aggressive,' says Mizuho https://t.co/LGa0cbYtgj
June 5th 2019, 12:06pm
fintel_io @fintel_io
$ATRA / Atara Biotherapeutics files form 8-K https://t.co/vkT7BHLiYq - Other Events
June 5th 2019, 11:06am
marketexclusive @marketexclusive
$ATRA Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Files An 8-K Other Events https://t.co/XFuece45aX
June 5th 2019, 9:06am
Briefingcom @Briefingcom
$ATRA: Atara Biotherapeutics updates on ongoing discussions with the FDA regarding the development of tab-cel https://t.co/0VGJVJSN4X
June 5th 2019, 8:06am
Hall8Jack @Hall8Jack
RT @bio_clouseau: $ATRA planning to combine 2 ongoing P3 in EBV based on discussions with FDA https://t.co/aZlrIgDIIx
June 5th 2019, 8:06am
bio_clouseau @bio_clouseau
$ATRA planning to combine 2 ongoing P3 in EBV based on discussions with FDA https://t.co/aZlrIgDIIx
June 5th 2019, 7:06am
Stock_News_Now @Stock_News_Now
$ATRA: New SEC Filing for ATRA: Form 8-K (No. 0001193125-19-165471): https://t.co/bMsPDrtGuB
June 5th 2019, 7:06am
filingsdb @filingsdb
New Form 8-K filed by Atara Biotherapeutics, Inc. $ATRA - https://t.co/TxqfYlXIVr
June 5th 2019, 6:06am
AlertTrade @AlertTrade
RT @Briefingcom: $ATRA: Atara Biotherapeutics announces presentation of updated Phase 1 clinical results for mesothelin-targeted CAR... htt…
June 4th 2019, 11:06am
Briefingcom @Briefingcom
$ATRA: Atara Biotherapeutics announces presentation of updated Phase 1 clinical results for mesothelin-targeted CAR… https://t.co/9lRAe2xlP2
June 4th 2019, 11:06am
firsttomarkets @firsttomarkets
Atara Biotherapeutics Inc Upgrade by Citigroup (Ranked 24th) to Neutral with $24PT $ATRA #ATRA https://t.co/sCYyZ17W01
June 4th 2019, 11:06am
ToothFrank @ToothFrank
$ATRA Atara Biotherapeutics shared an update Tuesday on positive results from an ongoing MSK investigator-sponsore… https://t.co/nwyuMZOHR7
June 4th 2019, 11:06am
newswithvalue @newswithvalue
$ATRA: Atara Biotherapeutics Announces Collaborator Presentation …: https://t.co/pf5vQ3jBCn
June 4th 2019, 10:06am
dailypoliticaln @dailypoliticaln
-$1.45 Earnings Per Share Expected for Atara Biotherapeutics Inc $ATRA This Quarter https://t.co/06K1fVSpcf
June 4th 2019, 7:06am
ZolmaxNews @ZolmaxNews
Citigroup Upgrades Atara Biotherapeutics $ATRA to “Neutral” https://t.co/2Iw1N70tlJ
June 4th 2019, 5:06am
AmericanBanking @AmericanBanking
Analysts’ Upgrades for June, 3rd $ATRA, CENTA, CHMG, CICOY, CLUB, COVTY, CRNT, CRVS, CVTI, DAVA https://t.co/zJXDxgc7eB #stocks
June 3rd 2019, 10:06pm
AmericanBanking @AmericanBanking
Citigroup Upgrades Atara Biotherapeutics $ATRA to Neutral https://t.co/tfk4oARIvZ #stocks
June 3rd 2019, 10:06pm
dailypoliticaln @dailypoliticaln
Analysts’ Upgrades for June, 3rd $ATRA, CENTA, CHMG, CICOY, CLUB, COVTY, CRNT, CRVS, CVTI, DAVA https://t.co/Vbkpo7w67w
June 3rd 2019, 10:06pm
TheMarketsDaily @TheMarketsDaily
Analysts Set Atara Biotherapeutics Inc $ATRA Target Price at $42.75 https://t.co/gvZIT93BFb
June 3rd 2019, 8:06pm
BernieBowman0 @BernieBowman0
RT @theflynews: Atara Biotherapeutics upgraded to Neutral from Sell at Citi $ATRA https://t.co/7RBQY3jOMY
June 3rd 2019, 7:06pm
theflynews @theflynews
Atara Biotherapeutics upgraded to Neutral from Sell at Citi $ATRA https://t.co/7RBQY3jOMY
June 3rd 2019, 6:06pm
PriceTargetsNet @PriceTargetsNet
$ATRA RATING UPGRADED AT CITI. https://t.co/Q9O3gRYpB0
June 3rd 2019, 5:06pm
ThisLincolnian @ThisLincolnian
Insider Selling: Atara Biotherapeutics Inc $ATRA CEO Sells 5,850 Shares of Stock https://t.co/3YOEHzaObc
June 3rd 2019, 5:06am
WKRBNews @WKRBNews
Atara Biotherapeutics $ATRA Coverage Initiated at Roth Capital https://t.co/ZO6WJ0OW49 #markets
June 3rd 2019, 4:06am
ConsumerFeed @ConsumerFeed
Atara Biotherapeutics $ATRA Coverage Initiated at Roth Capital https://t.co/N7Z5asMawv
June 3rd 2019, 4:06am
TranscriptDaily @TranscriptDaily
Wedbush Reaffirms Outperform Rating for Atara Biotherapeutics $ATRA https://t.co/5oPB9bHdJX
June 2nd 2019, 6:06am
stocknewstimes @stocknewstimes
Wedbush Reaffirms Outperform Rating for Atara Biotherapeutics $ATRA https://t.co/MRsyVTxoho
June 2nd 2019, 6:06am
SleekMoneycom @SleekMoneycom
Wedbush Reaffirms Outperform Rating for Atara Biotherapeutics $ATRA https://t.co/mkKryRBtQD #investing
June 2nd 2019, 6:06am
HottestStockNow @HottestStockNow
$ATRA Reveals Tab-cel®Clinical Biomarker Results and Nasopharyngeal Carcinoma Study Design https://t.co/7bFVzuBsz4
June 1st 2019, 8:06pm
bbnsnews @bbnsnews
Isaac E. Ciechanover Sells 5,850 Shares of Atara Biotherapeutics Inc $ATRA Stock https://t.co/1WtdRzdWhY
June 1st 2019, 1:06pm
ACInvestorBlog @ACInvestorBlog
$ATRA Atara Biotherapeutics Presents Tab-cel® Clinical Biomarker Results and Nasopharyngeal Carcinoma Study Design… https://t.co/p9VyfWDxe0
June 1st 2019, 1:06pm
SwingTradeBot @SwingTradeBot
Recent $ATRA technical alerts: New 52 Week Closing Low plus 8 more alerts... https://t.co/XAjsksRSfa
June 1st 2019, 12:06pm
dispatchtribune @dispatchtribune
Atara Biotherapeutics Inc $ATRA Receives $42.75 Average Target Price from Analysts https://t.co/FRki3VcrEm
June 1st 2019, 12:06pm
mannyfromguam @mannyfromguam
RT @john_craighead: #ASCO19 preview: Big Pharmas looking for cancer R&D revival as we hit next-gen crossroads @Atarabio $ATRA https://t.co/…
June 1st 2019, 10:06am
WeekHerald @WeekHerald
Atara Biotherapeutics $ATRA Research Coverage Started at Roth Capital https://t.co/hDA4H6TibQ
June 1st 2019, 4:06am
AmericanBanking @AmericanBanking
-$1.46 EPS Expected for Atara Biotherapeutics Inc $ATRA This Quarter https://t.co/T22BGpuLGV #stocks
June 1st 2019, 4:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.